GURUFOCUS.COM » STOCK LIST » Latin America » Mexico » MEX » Biogen Inc (MEX:BIIB) » Definitions » Dividend Payout Ratio
Switch to:

Biogen (MEX:BIIB) Dividend Payout Ratio

: 0.00 (As of Mar. 2023)
View and export this data going back to 2013. Start your Free Trial

Biogen's dividend payout ratio for the months ended in Mar. 2023 was 0.00.

The historical rank and industry rank for Biogen's Dividend Payout Ratio or its related term are showing as below:


MEX:BIIB's Dividend Payout Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.32
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2023-06-09), the Dividend Yield % of Biogen is 0.00%.

Biogen's Dividends per Share for the months ended in Mar. 2023 was MXN0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Biogen Dividend Payout Ratio Historical Data

The historical data trend for Biogen's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Dividend Payout Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biogen Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Dividend Payout Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - General subindustry, Biogen's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Biogen Dividend Payout Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Biogen's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Biogen's Dividend Payout Ratio falls in comparison to its industry or sector. The grey bar indicates the Dividend Payout Ratio's extreme value range as defined by GuruFocus.



Biogen Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Biogen's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2022 )/ EPS without NRI (A: Dec. 2022 )
=0/ 406.882
=0.00

Biogen's Dividend Payout Ratio for the quarter that ended in Mar. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2023 )/ EPS without NRI (Q: Mar. 2023 )
=0/ 48.127
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogen (MEX:BIIB) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Biogen Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Biogen's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogen (MEX:BIIB) Business Description

Biogen logo
Address
225 Binney Street, Cambridge, MA, USA, 02142
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.

Biogen (MEX:BIIB) Headlines